Since the overexpression of RGS2 inhibited insulin signaling in human endothelial cells, the next step was to quantify RGS2 expression levels in platelets from T2DM patients and compare them with those obtained from healthy people. The gene discussed is INS; the disease is type 2 diabetes mellitus.